Rep. Chris Deluzio, U.S. Representative for Pennsylvania's 17th District | Official U.S. House headshot
Rep. Chris Deluzio, U.S. Representative for Pennsylvania's 17th District | Official U.S. House headshot
Congressman Chris Deluzio has been vocal about his opinions on tariffs and Pharmacy Benefit Managers (PBMs) in a series of tweets from early April 2025. Deluzio, who has represented Pennsylvania's 17th district in the U.S. Congress since 2023, shared his insights on current trade practices and criticized the influence of corporate entities in the healthcare sector.
On April 2, 2025, Deluzio tweeted briefly: "My statement on today’s tariff news https://t.co/We9flJYXBe".
Deluzio followed up on April 3, 2025, with a more comprehensive statement on trade practices, expressing a nuanced stance. He tweeted: "Two things can be true at the same time. Donald Trump's chaotic use of tariffs alone won't kickstart American manufacturing AND the old unfair 'free trade' regime shipped our jobs away to enrich huge corporations. We can't go back to that. There's a better way to supercharge https://t.co/piJ5AhsqsT".
Continuing his critique on corporate entities, on April 4, 2025, Deluzio focused on PBMs. He tweeted: "Pharmacy Benefit Managers (PBMs) are corporate middlemen. They steer patients toward chain pharmacies, jack up prescription prices for all of us, and put independent, local pharmacies out of business. They're a villainous example of corporate power run amok. Unbelievable that https://t.co/lEDe1I20L5".
Alerts Sign-up